CBLL1 and colorectal cancer: Moreover, Hakai expression has also been studied in inflammatory bowel disease (IBD), which increases the risk of colorectal cancer (CRC) and includes conditions such as ulcerative colitis (UC) and Crohn’s disease (CD).